JPS60226878A - ３−アミノ−１−（４，５，６，７−テトラヒドロベンゾチアゾリル）−２−ピラゾリン類およびその製法 - Google Patents

３−アミノ−１−（４，５，６，７−テトラヒドロベンゾチアゾリル）−２−ピラゾリン類およびその製法

Info

Publication number
JPS60226878A
JPS60226878A JP60037803A JP3780385A JPS60226878A JP S60226878 A JPS60226878 A JP S60226878A JP 60037803 A JP60037803 A JP 60037803A JP 3780385 A JP3780385 A JP 3780385A JP S60226878 A JPS60226878 A JP S60226878A
Authority
JP
Japan
Prior art keywords
formula
compounds
pyrazoline
tetrahydrobenzothiazolyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60037803A
Other languages
English (en)
Japanese (ja)
Inventor
ヨーアヒム・ウーレンドルフ
ハーラルト・オー・ボルベ
ジーグルト・ライツク
ミヒアエル・ヨーン・パルンハム
ヘルムート・ヴエツイヒ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of JPS60226878A publication Critical patent/JPS60226878A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP60037803A 1984-03-01 1985-02-28 ３−アミノ−１−（４，５，６，７−テトラヒドロベンゾチアゾリル）−２−ピラゾリン類およびその製法 Pending JPS60226878A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3407506.2 1984-03-01
DE19843407506 DE3407506A1 (de) 1984-03-01 1984-03-01 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
JPS60226878A true JPS60226878A (ja) 1985-11-12

Family

ID=6229258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60037803A Pending JPS60226878A (ja) 1984-03-01 1985-02-28 ３−アミノ−１−（４，５，６，７−テトラヒドロベンゾチアゾリル）−２−ピラゾリン類およびその製法

Country Status (7)

Country Link
US (1) US4600722A (US07816562-20101019-C00012.png)
EP (1) EP0155523A1 (US07816562-20101019-C00012.png)
JP (1) JPS60226878A (US07816562-20101019-C00012.png)
DE (1) DE3407506A1 (US07816562-20101019-C00012.png)
DK (1) DK93385A (US07816562-20101019-C00012.png)
GR (1) GR850470B (US07816562-20101019-C00012.png)
ZA (1) ZA851547B (US07816562-20101019-C00012.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613592D0 (en) * 1986-06-04 1986-07-09 Roussel Lab Ltd Chemical compounds
US5300514A (en) * 1990-07-17 1994-04-05 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
CA2046672A1 (en) * 1990-07-17 1992-01-18 Raymond Frank Brown Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
US5399565A (en) * 1990-07-17 1995-03-21 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
UA53679C2 (uk) 1996-12-16 2003-02-17 Басф Акцієнгезелльшафт Заміщені піразол-3-ілбензазоли, спосіб їх одержання (варіанти), гербіцидний засіб та спосіб його одержання, засіб для десикації і/або дефоліації рослин та спосіб його одержання, спосіб боротьби з небажаним ростом рослин та спосіб десикації і/або дефоліації рослин
JP4759207B2 (ja) * 2000-05-15 2011-08-31 あすか製薬株式会社 １−（ベンゾチアゾール−２−イル）ピラゾール誘導体およびそれを含有するｃｏｘ−２阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1061812B (it) * 1976-06-25 1983-04-30 Montedison Spa Processo per la preparazione di i fenil 3 ammino pirazoli
JPS5334773A (en) * 1976-09-14 1978-03-31 Ube Ind Ltd Benzothiazole derivatives and preventives remedies containing the same for coccidiosis
IL59334A (en) * 1979-03-02 1984-01-31 Velsicol Chemical Corp Tetrahydrobenzothiazolylimidazolidinones and herbicidal compositions containing them
DE3017976A1 (de) * 1980-05-10 1981-11-19 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte 2-amino-5-halogen-benzothiazole, verfahen zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4376122A (en) * 1981-07-13 1983-03-08 American Cyanamid Company Novel 3-substituted amino-1-heteroaryl-2-pyrazolines
EP0070376A1 (en) * 1981-07-13 1983-01-26 American Cyanamid Company Heterocyclic substituted-amino-pyrazolines

Also Published As

Publication number Publication date
DE3407506A1 (de) 1985-09-05
DK93385D0 (da) 1985-02-28
DK93385A (da) 1985-09-02
EP0155523A1 (en) 1985-09-25
GR850470B (US07816562-20101019-C00012.png) 1985-05-31
US4600722A (en) 1986-07-15
ZA851547B (en) 1985-10-30

Similar Documents

Publication Publication Date Title
RU2142946C1 (ru) Производные пиразола и фармацевтическая композиция, содержащая их
JPS58109474A (ja) 新規イミダゾ−ル誘導体、その製法及び該化合物を含有する人の炎症性又はアレルギ−性疾患の治療用薬剤並びに偏頭及び月経困難症の治療用薬剤
HU184727B (en) Process for preparing 3-/1-imidazolyl-alkyl/-indole derivatives
JPH054391B2 (US07816562-20101019-C00012.png)
JP4833832B2 (ja) ピラゾール化合物
JPH03170465A (ja) ピリダジン誘導体、その製造方法及び該誘導体を含有する医薬組成物
JPS5930713B2 (ja) 新規な置換６−アリ−ル−４Ｈ−Ｓ−トリアゾロ−〔３，４Ｃ〕−チエノ−〔２，３ｅ〕−１，４−ジアゼピン類の製造方法
JP2707936B2 (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
JPS60226878A (ja) ３−アミノ−１−（４，５，６，７−テトラヒドロベンゾチアゾリル）−２−ピラゾリン類およびその製法
HU201015B (en) Process for producing pyridine derivatives
CZ2004639A3 (cs) Deuterované pyrazolpyrimidinony a léčiva obsahující tyto sloučeniny
JP2726999B2 (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
JPS6025990A (ja) トリアゾ−ル系ジオキソラン誘導体
HU191702B (en) New process for preparing 1-aryl-5 h-2,3-benzodiazepines
US3882119A (en) Tetracyclic substituted phthalazine compounds
US4500708A (en) Benzothiazine derivatives
US4772598A (en) 2-aryl-3,4-diazabicyclo(4.n.O)alk-2-en-5-ones for the preparation of an agent for treating cardiac insufficiency
KR830001838B1 (ko) 페닐-퀴놀리지딘의 제조방법
HUT54125A (en) Process for producing triazine derivatives and pharmaceutical compositions comprising same
JPS6245870B2 (US07816562-20101019-C00012.png)
US4548947A (en) 1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia
JPS5821634B2 (ja) シンキイミダゾ （１，２−ａ）ｓ− トリアジンルイノセイゾウホウホウ
JPS61249970A (ja) 新規な置換２−（ｎ−アルキニル−ｎ−フエニルアミノ）イミダゾリン誘導体
JPH04368375A (ja) イソオキサゾール誘導体
HU191597B (en) Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances